They confirmed that radiation and vemurafenib activate caspase-3 in melanoma cells and that dying melanoma cells treated with radiotherapy or vemurafenib stimulate the growth of viable tumor cells in vitro and in vivo. This evidence concerns the gene CASP3 and melanoma.